Annji Pharmaceutical Co., Ltd.
Records under this name other than the patents Annji Pharmaceutical Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.
Showing 1 to 3 of 3 · Back to Annji Pharmaceutical Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,969,361 | Cyclopropanecarboxylate esters of purine analogues Lapsed on the fee record Ended Mar 3, 2023 · USPTO record | Lapsed on the fee record | Ended Mar 3, 2023 | USPTO record |
| US 8,946,282 | Indolin-2-one derivatives as protein kinase inhibitors Lapsed on the fee record Ended Feb 3, 2023 · USPTO record | Lapsed on the fee record | Ended Feb 3, 2023 | USPTO record |
| US 9,302,992 | Multifunctional quinoline derivatives as anti-neurodegenerative agents Lapsed on the fee record Ended Apr 5, 2020 · USPTO record | Lapsed on the fee record | Ended Apr 5, 2020 | USPTO record |